1. Home
  2. HTHT vs RGEN Comparison

HTHT vs RGEN Comparison

Compare HTHT & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo H World Group Limited

HTHT

H World Group Limited

HOLD

Current Price

$45.07

Market Cap

13.8B

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$122.73

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTHT
RGEN
Founded
2005
1981
Country
China
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.8B
6.6B
IPO Year
2010
1995

Fundamental Metrics

Financial Performance
Metric
HTHT
RGEN
Price
$45.07
$122.73
Analyst Decision
Strong Buy
Buy
Analyst Count
4
12
Target Price
$56.60
$167.67
AVG Volume (30 Days)
2.4M
1.2M
Earning Date
05-19-2026
05-05-2026
Dividend Yield
4.07%
N/A
EPS Growth
N/A
286.96
EPS
N/A
0.15
Revenue
N/A
$141,236,000.00
Revenue This Year
$7.18
$14.30
Revenue Next Year
$6.71
$14.52
P/E Ratio
$30.34
$844.20
Revenue Growth
N/A
35.10
52 Week Low
$30.42
$100.99
52 Week High
$56.53
$175.77

Technical Indicators

Market Signals
Indicator
HTHT
RGEN
Relative Strength Index (RSI) 41.89 54.31
Support Level $44.42 $121.25
Resistance Level $45.90 $131.53
Average True Range (ATR) 1.32 5.91
MACD 0.16 1.46
Stochastic Oscillator 60.11 74.44

Price Performance

Historical Comparison
HTHT
RGEN

About HTHT H World Group Limited

H World Group Ltd a foremost, fast-growing multi-brand hotel group with international operations. The principal business activities of the Company are to develop and operate leased and owned, manachised and franchised hotels mainly in the PRC or PRC Mainland. The Group has two operating segments which are legacy Huazhu and legacy DH according to the way management intends to evaluate results and allocate resources within the Group. The majority of revenue comes from legacy Huazhu. The company has presence in Greater China and also Outside Greater China.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: